UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia

Blood, 2012-02, Vol.119 (5), p.1162-1172

2012

Volltextzugriff (PDF)

Dipeptidyl peptidase expression during experimental colitis in mice

Inflammatory bowel diseases, 2010-08, Vol.16 (8), p.1340-1351

2010

Volltextzugriff (PDF)

Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia

Cancer biology & therapy, 2010-07, Vol.10 (2), p.180-189

2010

Volltextzugriff (PDF)

Dipeptidyl peptidase 8 and 9--guilty by association?

Frontiers in bioscience, 2009-01, Vol.14 (10), p.3619-3633

2009

Volltextzugriff (PDF)

Dipeptidyl peptidase expression during experimental colitis in mice

Inflammatory bowel diseases, 2010-08, Vol.16 (8), p.1340-1351

2010

Volltextzugriff (PDF)

HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia

Clinical cancer research, 2016-07, Vol.22 (14), p.3537-3549

2016

Volltextzugriff (PDF)

DPIV/CD26 and FAP in cancer: a tale of contradictions

Advances in experimental medicine and biology, 2006, Vol.575, p.197

2006

Volltextzugriff (PDF)

HDAC Inhibition Induces microRNA-182 Which Targets Rad51 Protein and Impairs Homologous Recombination Repair to Sensitize Cells to the Double Strand Break Inducing Nucleoside Analog, Sapacitabine in AML

Blood, 2015-12, Vol.126 (23), p.3639-3639

2015

Volltextzugriff (PDF)

Abstract 120: Epigenetic silencing of miR-17 and miR-20a in chronic lymphocytic leukemia

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.120-120

2012

Volltextzugriff (PDF)

The Safety and Tolerability of Oral Fludarabine, ±oral Cyclophosphamide and Iv Rituximab Therapy In Previously Untreated Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – Interim Analysis From the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study

Blood, 2010-11, Vol.116 (21), p.699-699

2010

Volltextzugriff (PDF)

2.53 HDAC-Mediated Silencing of miR-17 and miR-20a in Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S193-S194

2011

Volltextzugriff (PDF)

5.25 Safety and Tolerability of Oral Fludarabine, with or without Oral Cyclophosphamide and Intravenous Rituximab Therapy, in Previously Untreated Patients with Chronic Lymphocytic Leukaemia Aged 65 Years or Older: Second Interim Analysis from the Australasian Leukaemia and Lymphoma Group and CLL Australian Research Consortium CLL5 Study

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S259-S260

2011

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia

Dipeptidyl peptidase expression during experimental colitis in mice

Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia

Dipeptidyl peptidase 8 and 9--guilty by association?

Dipeptidyl peptidase expression during experimental colitis in mice

HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia

DPIV/CD26 and FAP in cancer: a tale of contradictions

HDAC Inhibition Induces microRNA-182 Which Targets Rad51 Protein and Impairs Homologous Recombination Repair to Sensitize Cells to the Double Strand Break Inducing Nucleoside Analog, Sapacitabine in AML

Abstract 120: Epigenetic silencing of miR-17 and miR-20a in chronic lymphocytic leukemia

A Randomised Dose De-Escalation Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years: Final Analysis of Response and Toxicity

Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL)

2.53 HDAC-Mediated Silencing of miR-17 and miR-20a in Chronic Lymphocytic Leukemia

Suchergebnisse filtern